REQUEST A DEMO
Total
USD $0.00
Search more companies

Hi-Clearance Inc. (Taiwan, China)

Main Activities: Miscellaneous Manufacturing
Full name: Hi-Clearance Inc. Profile Updated: May 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Xing Chang Biotech Co., Ltd. (Hi-Clearance Inc.) was established in February 1989.In the early days the company distributed Japan TORAY memorials products and was engaged in the dialysis medical equipment and supplies sales. In August 1995 it introduced Spanish IDEMSA artificial kidney and worked as sales agent of TORAY cardiac categorization products. In March 1995 it commissioned Thai INFUS to OEM manufacture its own brand "HEMOCARE".In October 2000 it was renamed "Apricot Chang Biotechnology" from the original name "Apricot Chang Industry". In September 2003 it went public. In March 2004 it set up High Peak Trading Ltd. in the mainland. The products include the artificial kidney, dialysis machine, the blood circuit tube, dialysis medicine and powder and Erythropoietin.

Headquarters
8F.2,No.2,Ln.609,Sec.5,Chongxin Rd.,Sanchong Dist
New Taipei City; New Taipei City;

Contact Details: Purchase the Hi-Clearance Inc. report to view the information.

Website: http://www.hiclearance.com.tw

Basic Information
Total Employees:
Purchase the Hi-Clearance Inc. report to view the information.
Outstanding Shares:
Purchase the Hi-Clearance Inc. report to view the information.
Financial Auditors:
Purchase the Hi-Clearance Inc. report to view the information.
Incorporation Date:
February 13, 1989
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
14.64%
Purchase this report to view the information.
5.36%
Purchase this report to view the information.
3.02%
Purchase this report to view the information.
1.18%
Purchase this report to view the information.
1.04%
Subsidiaries
Succeed Agents Limited (United Kingdom)
100%
宏醫實業股份有限公司
100%
杏昌健康服務股份有限公司
100%
Company Performance
Financial values in the chart are available after Hi-Clearance Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
6.88%
Total operating revenue
7.85%
Operating profit (EBIT)
27.07%
EBITDA
11.05%
Net Profit (Loss) for the Period
15.56%
Total assets
10.57%
Total equity
2.24%
Operating Profit Margin (ROS)
1.9%
Net Profit Margin
0.75%
Return on Equity (ROE)
0.82%
Debt to Equity Ratio
28.87%
Quick Ratio
-0.29%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?